Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Biochemical Pharmacology|July 28, 2025
Recent advances in colony stimulating factor-1 receptor (CSF1R) inhibitorsLing Peng, Zhou Fang, Wen Zhang, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|June 20, 2020
New insight into the photoinduced wavelength dependent decay mechanisms of the ferulic acid system on the excited statesCong-Neng Cao, Cheng-Fu Liu, Li Zhao, et al.Current Medicinal Chemistry|October 12, 2021
Research Status, Synthesis and Clinical Application of Recently Marketed and Clinical BCR-ABL InhibitorsXiao-Liang Xu, Yu-Jing Cao, Wen Zhang, et al.Current Medicinal Chemistry|August 31, 2022
Protein Lysine Methyltransferases InhibitorsYing Li, Lei Ding, Shuang Ren, et al.Future Medicinal Chemistry|August 11, 2022
New application of novel tetrazine derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agentsQuan Zheng, Kang Cheng, Hao Jin, et al.Current Medicinal Chemistry|February 3, 2023
Research Progress in the Clinical Treatment of Familial HypercholesterolemiaJing-Yan Ai, Peng-Cheng Zhao, Wen Zhang, et al.Drug Discovery Today|April 25, 2024
Current status of drugs targeting PDGF/PDGFRJing-Yan Ai, Chen-Fu Liu, Wen Zhang, et al.Bioorganic Chemistry|December 21, 2024
Targeting XPO1 for fighting relapsed/refractory diseases: The research progress of XPO1 inhibitorsYe-Qin Li, Zhou Fang, Wen Zhang, et al.Bioorganic Chemistry|December 21, 2025
Research progress of drugs targeting GPC3 in cancer therapyYe-Qin Li, Yuan Liao, Wen Zhang, et al.Chemistry & Biodiversity|September 12, 2021
Synthesis and Anti-Proliferation Activity Evaluation of Novel 2-Chloroquinazoline as Potential EGFR-TK InhibitorsQuan Zheng, Xuan-Bo Xu, Hao Jin, et al.Pageof 6